1. Home
  2. SATL vs KALV Comparison

SATL vs KALV Comparison

Compare SATL & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Satellogic Inc.

SATL

Satellogic Inc.

HOLD

Current Price

$9.50

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.81

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SATL
KALV
Founded
2010
N/A
Country
United States
United States
Employees
154
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SATL
KALV
Price
$9.50
$26.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$5.50
$32.60
AVG Volume (30 Days)
9.0M
3.9M
Earning Date
05-12-2026
07-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$50,000,000.00
Revenue This Year
$88.89
$185.42
Revenue Next Year
$56.98
$59.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
495.66
52 Week Low
$1.26
$9.83
52 Week High
$12.00
$26.85

Technical Indicators

Market Signals
Indicator
SATL
KALV
Relative Strength Index (RSI) 57.77 74.29
Support Level $3.28 $14.22
Resistance Level N/A $26.85
Average True Range (ATR) 1.02 0.06
MACD 0.01 -0.28
Stochastic Oscillator 49.29 76.47

Price Performance

Historical Comparison
SATL
KALV

About SATL Satellogic Inc.

Satellogic Inc is a vertically integrated Earth observation company that designs, manufactures, and operates satellite systems, delivering decision-grade insights at scale to government and commercial customers. Through an end-to-end production and operations model, it provides governments with flexible options across their journey toward sovereign Earth observation. From access to high-frequency imagery and managed space systems to full satellite ownership, to supporting autonomous data availability and long-term technological independence. It has monitoring and alert-driven workflows that help defense and intelligence agencies, civil governments, and commercial operators transition from reactive tasking to proactive decision-making, providing mission-critical data when needed.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: